None listed
Conditions
Interventions
None listed
Sponsors
The Catholic University of Korea, St. Vincent's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) All patients over the age of 19 with coronary artery disease who receive the UltimasterTM tansei stent 2) patients or legal guardians voluntarily signing the consent form and agreeing with the study protocol and the schedule for clinical follow-up.
Exclusion criteria
Exclusion criteria: 1) Patients treated with different drug stents at the time of research registration 2) Patients whose life expectancy are less than 1 year 3) Patients with cardiogenic shock or severe pulmonary edema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined clinical events which involve death, myocardial infarction(non-fatal) or target vessel revascularization (TVR) at 12 months after coronary intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Each of the following events which involve the followings at 12 months after coronary intervention (1) All deaths (2) Cardiac death (3) Myocardial infarction (MI) (4) Composite of death and myocardial infarction (5) Composite of cardiac death and myocardial infarction (6) Composite of death, myocardial infarction, and target vessel revascularization (7) Composite of cardiac death, myocardial infarction, and target vessel revascularization (8) Composite of death, myocardial infarction, and target lesion revascularization (9) Composite of cardiac death, myocardial infarction, target lesion revascularization (10) Target vessel revascularization (TVR) (11) Target lesion revascularization (TLR) (12) Stent thrombosis (ARC standard) (13) Procedure success(Case where there was no death nor Q-wave myocardial infarction or urgent revascularization during hospitalization as less 30% of final residual stenosis in evaluation by angiography naked eye after procedure) | — |
Countries
Korea, Republic of
Contacts
Public ContactGyung-Min Park
Ulsan Univeristy Hospital
Outcome results
None listed